LinkedIn Profile

Access Denali Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
private:denalitherapeutics 9435633 Nov 18th, 2019 12:00AM Denali Therapeutics 8.8K 253.00 Open Biotechnology Nov 18th, 2019 04:08PM Nov 18th, 2019 04:08PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 17th, 2019 12:00AM Denali Therapeutics 8.8K 253.00 Open Biotechnology Nov 17th, 2019 04:33PM Nov 17th, 2019 04:33PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 16th, 2019 12:00AM Denali Therapeutics 8.8K 253.00 Open Biotechnology Nov 16th, 2019 04:27PM Nov 16th, 2019 04:27PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 15th, 2019 12:00AM Denali Therapeutics 8.8K 253.00 Open Biotechnology Nov 15th, 2019 01:06PM Nov 15th, 2019 01:06PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 13th, 2019 12:00AM Denali Therapeutics 8.7K 253.00 Open Biotechnology Nov 13th, 2019 01:29PM Nov 13th, 2019 01:29PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 12th, 2019 12:00AM Denali Therapeutics 8.7K 253.00 Open Biotechnology Nov 12th, 2019 03:10PM Nov 12th, 2019 03:10PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 11th, 2019 12:00AM Denali Therapeutics 8.7K 253.00 Open Biotechnology Nov 11th, 2019 03:08PM Nov 11th, 2019 03:08PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 10th, 2019 12:00AM Denali Therapeutics 8.7K 253.00 Open Biotechnology Nov 10th, 2019 06:15PM Nov 10th, 2019 06:15PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 9th, 2019 12:00AM Denali Therapeutics 8.7K 253.00 Open Biotechnology Nov 9th, 2019 05:42PM Nov 9th, 2019 05:42PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080
private:denalitherapeutics 9435633 Nov 8th, 2019 12:00AM Denali Therapeutics 8.7K 253.00 Open Biotechnology Nov 8th, 2019 02:54PM Nov 8th, 2019 02:54PM Denali Therapeutics Inc. (“Denali”) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors). Open Biotechnology, Neurodegenerative Disease, Neurodegeneration, Pharmaceuticals Open 151 Oyster Point Blvd, Building 3, Floor 2 South San Francisco CA US 94080

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.